This activity generates tables and figures for a clinical study conducted by Pymaceuticals, Inc., a hypothetical pharmaceutical company that specializes in anti-cancer medications.

The purpose of this study was to compare the performance of Pymaceuticalsâ€™ drug of interest, Capomulin, against the other treatment regimens.

- The data from Pymaceuticals most recent animal study consists of 249 mice who were identified with squamous cell carcinoma (SCC) tumors and received treatment with a range of drug regimens. Over the course of 45 days, tumor development was observed and measured. 

